©The Author(s) 2018.
World Journal of Gastrointestinal Surgery. Aug 27, 2018; 10(5): 49-56
Published online Aug 27, 2018. doi: 10.4240/wjgs.v10.i5.49
Published online Aug 27, 2018. doi: 10.4240/wjgs.v10.i5.49
Table 4 Complications of complete cytoreductive surgery/hyperthermic intraperitoneal chemotherapy
| Ref. | Year | Type of study | No. of patients | Complication(s) |
| Hamilton et al[32] | 2016 | Retrospective | 42 | Intrabdominal abscess: 9.5% |
| Bleeding: 9.1% | ||||
| Pleural effusion: 7.1% | ||||
| Anastomotic leak: 7.1% | ||||
| Renal failure: 2.4% | ||||
| Chua et al[18] | 2012 | Retrospective | 2020 | Post-op mortality 2% |
| Major complications grade III/IV: 24% | ||||
| Recurrence: 19% | ||||
| Chua et al[31] | 2009 | Systematic Review | NA | Hematological toxicity: 28% |
| Reoperation rates: 23% | ||||
| Sepsis: 14% | ||||
| Fistula: 23% | ||||
| Abscess: 37% | ||||
| Ileus: 86% | ||||
| Perforation: 10% | ||||
| Anastomotic leak: 9% | ||||
| DVT/PE: 9% | ||||
| Renal insufficiency: 7% |
- Citation: Rizvi SA, Syed W, Shergill R. Approach to pseudomyxoma peritonei. World Journal of Gastrointestinal Surgery 2018; 10(5): 49-56
- URL: https://www.wjgnet.com/1948-9366/full/v10/i5/49.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v10.i5.49